- Tariquidar
Drugbox
IUPAC_name = "N"- [2-[ 4- [2-(6,7-Dimethoxy-3,4-dihydro-1"H"-isoquinolin-2-yl)ethyl] phenyl] carbamoyl] -4,5-dimethoxyphenyl] quinoline-3-carboxamide
CAS_number = 206873-63-4
CAS_supplemental =
ATC_prefix =
ATC_suffix =
ATC_supplemental =
PubChem = 148201
DrugBank =
chemical_formula =
C=38 | H=38 | N=4 | O=6
molecular_weight = 646.73 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =Tariquidar (INN/USAN) is an P-glycoprotein inhibitor [Robey RW, Shukla S, Finley EM, Oldham RK, Barnett D, Ambudkar SV, Fojo T, Bates SE. Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)). Biochem Pharmacol" 2008;3:1302-12. PMID 18234154.] undergoing research for the treatment of cancer.
References
Wikimedia Foundation. 2010.